SEI Investments’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
RCM
LCM
SCM
BCLSI
SEI Investments's CCCC Position: Q2 2026 in Review
SEI Investments increased its C4 Therapeutics (CCCC) stake by 69% in Q2 2026, buying an estimated $59K and bringing the position to 42,376 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.
SEI Investments first reported a position in CCCC in Q3 2022 and has held it in 8 quarters since. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.
- SEI Investments held 42,376 shares of C4 Therapeutics worth $198K as of Q2 2026.
- SEI Investments bought 17,242 C4 Therapeutics shares in Q2 2026, an estimated $59K.
- C4 Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3044 holding.
- SEI Investments first reported a position in C4 Therapeutics in Q3 2022 and has held it in 8 quarters since.
- 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.